Pioneering disease investigator and beloved global health mentor Joel Breman died on April 6 at the age of 87. Breman was part of the team that investigated the first known Ebola outbreak in 1976.
Ebola is one of the most feared infectious diseases, with more than half of those infected dying. A vaccine has now been shown to cut that mortality rate in half.
Two scientists, one Nigerian and one American, created a cutting-edge surveillance network to catch the next emerging disease before it becomes a pandemic.
Dr. Daniel Bausch says of his work, "You realize that's all on the response side." He's come to appreciate that "the impact is with trying to change the system."
We asked public health leaders what the World Health Organization should add to its docket in this anniversary year. Answers ranged from pay more attention to teen health to restore the world's trust.
Marburg virus is hard to detect early on--and goes on to kill about half its victims. Researchers hope to work quickly during this outbreak to make progress on emerging vaccines and treatments.
Since the outbreak began in September, eight children have died — and there is no approved vaccine. But doctors are hopeful that public health measures may be enough to stop the spread.
Dr. Benjamin Black talks about Belly Woman: Birth, Blood and Ebola — the inside story of what it was like to face a terrifying epidemic in West Africa.
With an outbreak of the deadly disease declared in Uganda, travelers who have been to the African country within 21 days of arriving in the U.S. will be subject to enhanced screening.
The New Humanitarian first reported on the scandal from the Ebola crisis in 2020. Now the WHO has issued its own report, citing 83 allegations. And it's drawing criticism for investigating itself.
The Democratic Republic of Congo beat its second-worst outbreak of the Ebola virus in June. The new victims indicate the disease's resurgence in the area.
Regeneron — the pharmaceutical company developing COVID-19 treatments — has received FDA approval for the first drug aimed at another infectious disease that's been in the headlines.
The diagnosis — delivered at a distance of 6 feet in the doctor's office — was a shock. It brought back memories of my work in the Ebola ward. Then as now, an intimate touch was a rare thing.
It’s been five years as of this summer since the first U.S. Ebola patient went to Emory University Hospital. On Second Thought looks back on the events...
